Diprolene Glycol · DIN 00688622 · 0.05% · Cr
General benefit; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.Discontinued June 28, 2019 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Diprolene Glycol · DIN 00688622
Manufacturer: Schering Canada Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2019-06-28 · brand DIPROLENE · ATC D07AC01 BETAMETHASONE · form Cream · route Topical · ingredients BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %/W/W · company Merck canada inc · schedule Prescription
Diprolene Glycol: Formulary list price $0.52 per unit (the source does not state the unit; exact figure $0.5186). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00688622)
Source record
DIN 00688622: Diprolene Glycol
Raw flags: sec3=Y
Item: 840600105; group id 838; item number 2035; lccId None; manufacturer id SCH
Source form: Cr; strength: 0.05%
Recorded listing: General benefit
Source prices (unrounded): $0.5186; ministry $0.5186
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00688622
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8190
Therapeutic Notes (formulary)
No more than 50 grams per week of ultrapotent steroids for a maximum of 2 weeks is recommended.
Interchangeable products
Ratio-Topilene · DIN 00849650 · $0.5186
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 28, 2019 — choose a marketed DIN from the same-category list.